3 Health Services Stocks Dragging The Industry Down

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 17 points (-0.1%) at 17,039 as of Tuesday, July 15, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 915 issues advancing vs. 2,069 declining with 174 unchanged.

The Health Services industry currently sits down 0.8% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Accelerate Diagnostics ( AXDX), down 9.4%, Boston Scientific ( BSX), down 2.7%, Stryker Corporation ( SYK), down 1.3% and Abbott Laboratories ( ABT), down 1.2%. A company within the industry that increased today was Edwards Lifesciences ( EW), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Agilent Technologies ( A) is one of the companies pushing the Health Services industry lower today. As of noon trading, Agilent Technologies is down $0.48 (-0.8%) to $56.34 on average volume. Thus far, 870,389 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $56.15-$56.88 after having opened the day at $56.70 as compared to the previous trading day's close of $56.82.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $18.9 billion and is part of the health care sector. Shares are down 1.0% year-to-date as of the close of trading on Monday. Currently there are 9 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, CR Bard ( BCR) is down $1.77 (-1.2%) to $145.20 on average volume. Thus far, 299,744 shares of CR Bard exchanged hands as compared to its average daily volume of 781,000 shares. The stock has ranged in price between $144.99-$147.35 after having opened the day at $147.00 as compared to the previous trading day's close of $146.97.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. CR Bard has a market cap of $11.1 billion and is part of the health care sector. Shares are up 9.7% year-to-date as of the close of trading on Monday. Currently there are 2 analysts that rate CR Bard a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates CR Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, expanding profit margins and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CR Bard Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, St Jude Medical ( STJ) is down $1.18 (-1.7%) to $68.44 on heavy volume. Thus far, 1.7 million shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $68.40-$70.00 after having opened the day at $69.43 as compared to the previous trading day's close of $69.61.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $19.9 billion and is part of the health care sector. Shares are up 12.4% year-to-date as of the close of trading on Monday. Currently there are 15 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

DOJ Seeks to Block AT&T's Acquisition of Time Warner: LIVE MARKETS BLOG

DOJ Seeks to Block AT&T's Acquisition of Time Warner: LIVE MARKETS BLOG

Wall Street Finishes in the Green After Two Weeks of Losses

Wall Street Finishes in the Green After Two Weeks of Losses

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses